Intelligent Bio Solutions Common Stock Net 2020-2025 | INBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions common stock net from 2020 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Intelligent Bio Solutions common stock net from 2020 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$141.1B
CVS Health (CVS)	$79B
Elevance Health (ELV)	$61.8B
Cencora (COR)	$55.9B
DiDi Global (DIDIY)	$23.4B
Labcorp Holdings (LH)	$21.9B
Natera (NTRA)	$18.4B
BioMerieux (BMXMF)	$17.1B
EUROFINS SCIENT (ERFSF)	$15.1B
ICON (ICLR)	$13.4B
CochLear (CHEOY)	$13.2B
Solventum (SOLV)	$12.4B
Medpace Holdings (MEDP)	$11.9B
Revvity (RVTY)	$10.4B
Viatris (VTRS)	$10.3B
Sonic Healthcare (SKHHY)	$8.7B
Charles River Laboratories (CRL)	$8.2B
HealthEquity (HQY)	$7.9B
Avantor (AVTR)	$7.7B
Caris Life Sciences,�Inc (CAI)	$7.1B
Bausch + Lomb (BLCO)	$4.8B
Amplifon S.p.A (AMFPF)	$3.9B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.2B
GeneDx Holdings (WGS)	$2.9B
Surgery Partners (SGRY)	$2.7B
Alignment Healthcare (ALHC)	$2.6B
Organon (OGN)	$2.5B
Concentras Parent (CON)	$2.5B
Progyny (PGNY)	$1.9B